Su1068 Treatment of Previously Untreated Patients With Chronic HCV Genotype 1 Infection With Boceprevir in German Real-Life: High Efficacy in Patients With Early Virologic Response

Hcv Genotype ◽

Hcv Genotype 1 ◽

Treatment of previously untreated patients with chronic HCV genotype 1 infection with Boceprevir (BOC) in German real-life: High efficacy in patients with early virologic response

10.1055/s-0034-1386298 ◽

2014 ◽

Vol 52 (08) ◽

Author(s):

P Buggisch ◽

H Löhr ◽

G Teuber ◽

H Steffens ◽

M Kraus ◽

...

Keyword(s):

Real Life ◽

Virologic Response ◽

Genotype 1 ◽

High Efficacy ◽

Hcv Genotype ◽

Hcv Genotype 1 ◽

Treatment of previously untreated patients with chronic HCV genotype 1 infection with boceprevir in German real-life: high end of treatment response of 95% in patients with early virologic response

10.1055/s-0034-1397256 ◽

2015 ◽

Vol 53 (01) ◽

Author(s):

P Buggisch ◽

H Löhr ◽

G Teuber ◽

H Steffens ◽

M Kraus ◽

...

Keyword(s):

Treatment Response ◽

Real Life ◽

Virologic Response ◽

Genotype 1 ◽

Hcv Genotype ◽

End Of Treatment ◽

Hcv Genotype 1 ◽

Baseline predictors of an early virologic response (EVR) in previously untreated patients undergoing boceprevir (BOC) triple therapy for HCV genotype 1 infection in German real-life

10.1055/s-0034-1397212 ◽

2015 ◽

Vol 53 (01) ◽

Author(s):

P Buggisch ◽

H Löhr ◽

G Teuber ◽

H Steffens ◽

M Kraus ◽

...

Keyword(s):

Triple Therapy ◽

Real Life ◽

Virologic Response ◽

Genotype 1 ◽

Hcv Genotype ◽

Hcv Genotype 1

Boceprevir triple therapy of HCV genotype 1 (G1) infection in German real-life: comparable high SVR rates up to 87% in treatment-naïve and previously treated patients who achieve an early virologic response

10.1055/s-0035-1559171 ◽

2015 ◽

Vol 53 (08) ◽

Author(s):

P Buggisch ◽

H Löhr ◽

G Teuber ◽

H Steffens ◽

M Kraus ◽

...

Keyword(s):

Triple Therapy ◽

Real Life ◽

Virologic Response ◽

Genotype 1 ◽

Hcv Genotype ◽

Treatment Naïve ◽

Previously Treated Patients ◽

Previously Treated ◽

Hcv Genotype 1

P1137 TREATMENT OF CHRONIC HCV GENOTYPE 1 (G1) INFECTION WITH BOCEPREVIR IN GERMAN REAL-LIFE: HIGH EFFICACY TOGETHER WITH MODERATE TREATMENT DISCONTINUATION RATES IN TREATMENT-NAIVE PATIENTS

Journal of Hepatology ◽

10.1016/s0168-8278(14)61297-6 ◽

2014 ◽

Vol 60 (1) ◽

pp. S461

Author(s):

P. Buggisch ◽

H. Löhr ◽

G. Teuber ◽

H. Steffens ◽

M.R. Kraus ◽

...

Keyword(s):

Real Life ◽

Treatment Discontinuation ◽

Genotype 1 ◽

High Efficacy ◽

Hcv Genotype ◽

Treatment Naïve ◽

Hcv Genotype 1 ◽

Boceprevir triple therapy of chronic HCV genotype 1 (G1) infection in previously untreated patients: Efficacy, predictability of virologic response and safety in German real-life

10.1055/s-0035-1567994 ◽

2015 ◽

Vol 53 (12) ◽

Author(s):

P Buggisch ◽

H Löhr ◽

G Teuber ◽

H Steffens ◽

M Kraus ◽

...

Keyword(s):

Triple Therapy ◽

Real Life ◽

Virologic Response ◽

Genotype 1 ◽

Hcv Genotype ◽

Hcv Genotype 1 ◽

High virologic response rate at End of Treatment (EOT) following triple therapy of previously untreated HCV Genotype 1 (G1) infection with boceprevir in German real-life

10.1055/s-0034-1386302 ◽

2014 ◽

Vol 52 (08) ◽

Author(s):

P Buggisch ◽

H Löhr ◽

G Teuber ◽

H Steffens ◽

M Kraus ◽

...

Keyword(s):

Triple Therapy ◽

Response Rate ◽

Real Life ◽

Virologic Response ◽

Genotype 1 ◽

Hcv Genotype ◽

End Of Treatment ◽

Hcv Genotype 1 ◽

Virologic Response Rate

912 LEUKOCYTE DECLINE PREDICTS SUSTAINED VIROLOGIC RESPONSE IN PATIENTS UNDERGOING PEGINTERFERON alfa-2b/RIBAVIRIN TREATMENT OF CHRONIC HCV GENOTYPE 1 INFECTION

Journal of Hepatology ◽

10.1016/s0168-8278(13)60914-9 ◽

2013 ◽

Vol 58 ◽

pp. S376

Author(s):

G. Teuber ◽

S. Mauss ◽

D. Hüppe ◽

E. Zehnter ◽

M.P. Manns ◽

...

Keyword(s):

Sustained Virologic Response ◽

Virologic Response ◽

Genotype 1 ◽

Hcv Genotype ◽

Hcv Genotype 1 ◽

Chronic Hcv ◽

Peginterferon Alfa

Thyroid dysfunction induced by peginterferon alfa-2b (Peg-2b)/Ribavirin (Rbv) is associated with higher SVR rates in patients with HCV Genotype 1 (G1) infection due to improved early virologic response at week 4 and week 12

10.1055/s-0033-1352956 ◽

2013 ◽

Vol 51 (08) ◽

Author(s):

S Mauss ◽

D Hüppe ◽

E Zehnter ◽

MP Manns ◽

G Teuber ◽

...

Keyword(s):

Thyroid Dysfunction ◽

Virologic Response ◽

Genotype 1 ◽

Hcv Genotype ◽

Hcv Genotype 1 ◽

Peginterferon Alfa

Factors associated with rapid and early virologic response to peginterferon alfa-2a/ribavirin treatment in HCV genotype 1 patients representative of the general chronic hepatitis C population

Journal of Viral Hepatitis ◽

10.1111/j.1365-2893.2009.01157.x ◽

2010 ◽

Vol 17 (2) ◽

pp. 139-147 ◽

Cited By ~ 22

Author(s):

M. Rodriguez-Torres ◽

M. S. Sulkowski ◽

R. T. Chung ◽

F. M. Hamzeh ◽

D. M. Jensen

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Virologic Response ◽

Genotype 1 ◽

Hcv Genotype ◽

Factors Associated ◽

Hcv Genotype 1 ◽

Peginterferon Alfa